交易 Relay Therapeutics, Inc. - RLAY CFD
加入收藏夹- 概括
- 曆史數據
- 活動
- 收入報表
- 資産負債表
- 現金流
交易條件
价差 | 0.06 | ||||||||
多头隔夜费
多头隔夜费
前往平台 | -0.026179% | ||||||||
空头隔夜费
空头隔夜费
前往平台 | 0.003957% | ||||||||
隔夜费时间 | 21:00 (UTC) | ||||||||
最小交易量 | 1 | ||||||||
货币 | USD | ||||||||
保证金 | 5% | ||||||||
上市交易所 | United States of America | ||||||||
交易费 | 0% |
*Information provided by Capital.com
Relay Therapeutics Inc ESG Risk Ratings
High Medium Low Negligible
“B”分數表示相對 ESG 表現良好,公開報告重要 ESG 數據的透明度高於平均水平。
- 上週
- 上個月
- 去年
- 過去兩年
- 最大
- 每日
- 每週
- 每月
日期 | 關閉 | 更改 | 變化 (%) | 打開 | 高 | 低 |
---|---|---|---|---|---|---|
Apr 22, 2024 | 5.91 | -0.01 | -0.17% | 5.92 | 6.02 | 5.75 |
Apr 19, 2024 | 5.91 | -0.11 | -1.83% | 6.02 | 6.31 | 5.89 |
Apr 18, 2024 | 6.08 | 0.07 | 1.16% | 6.01 | 6.35 | 5.90 |
Apr 17, 2024 | 6.19 | -0.42 | -6.35% | 6.61 | 6.70 | 6.00 |
Apr 16, 2024 | 6.68 | 0.04 | 0.60% | 6.64 | 6.97 | 6.54 |
Apr 15, 2024 | 6.76 | -0.18 | -2.59% | 6.94 | 6.98 | 6.66 |
Apr 12, 2024 | 7.00 | -0.05 | -0.71% | 7.05 | 7.13 | 6.94 |
Apr 11, 2024 | 7.10 | 0.16 | 2.31% | 6.94 | 7.12 | 6.77 |
Apr 10, 2024 | 6.86 | 0.12 | 1.78% | 6.74 | 6.98 | 6.74 |
Apr 9, 2024 | 7.28 | 0.29 | 4.15% | 6.99 | 7.34 | 6.99 |
Apr 8, 2024 | 7.15 | 0.29 | 4.23% | 6.86 | 7.18 | 6.75 |
Apr 5, 2024 | 6.87 | 0.15 | 2.23% | 6.72 | 7.19 | 6.66 |
Apr 4, 2024 | 6.92 | -0.16 | -2.26% | 7.08 | 7.30 | 6.91 |
Apr 3, 2024 | 6.87 | -0.57 | -7.66% | 7.44 | 7.49 | 6.86 |
Apr 2, 2024 | 7.55 | -0.19 | -2.45% | 7.74 | 7.74 | 7.50 |
Apr 1, 2024 | 7.99 | -0.13 | -1.60% | 8.12 | 8.14 | 7.88 |
Mar 28, 2024 | 8.24 | 0.29 | 3.65% | 7.95 | 8.39 | 7.93 |
Mar 27, 2024 | 8.14 | 0.63 | 8.39% | 7.51 | 8.17 | 7.46 |
Mar 26, 2024 | 7.53 | 0.05 | 0.67% | 7.48 | 7.78 | 7.45 |
Mar 25, 2024 | 7.49 | -0.17 | -2.22% | 7.66 | 7.94 | 7.37 |
Relay Therapeutics, Inc. Events
时间(协调世界时) (UTC) | 国家 | 事件 |
---|---|---|
Thursday, May 2, 2024 | ||
时间(协调世界时) (UTC) 10:59 | 国家 US
| 事件 Q1 2024 Relay Therapeutics Inc Earnings Release Q1 2024 Relay Therapeutics Inc Earnings ReleaseForecast(预报) -上一页 - |
Tuesday, May 14, 2024 | ||
时间(协调世界时) (UTC) 15:30 | 国家 US
| 事件 Relay Therapeutics Inc at Citizens JMP Life Sciences Conference Relay Therapeutics Inc at Citizens JMP Life Sciences ConferenceForecast(预报) -上一页 - |
时间(协调世界时) (UTC) 20:40 | 国家 US
| 事件 Relay Therapeutics Inc at Bank of America Health Care Conference Relay Therapeutics Inc at Bank of America Health Care ConferenceForecast(预报) -上一页 - |
Thursday, May 30, 2024 | ||
时间(协调世界时) (UTC) 14:00 | 国家 US
| 事件 Relay Therapeutics Inc Annual Shareholders Meeting Relay Therapeutics Inc Annual Shareholders MeetingForecast(预报) -上一页 - |
Tuesday, August 6, 2024 | ||
时间(协调世界时) (UTC) 10:59 | 国家 US
| 事件 Q2 2024 Relay Therapeutics Inc Earnings Release Q2 2024 Relay Therapeutics Inc Earnings ReleaseForecast(预报) -上一页 - |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
總收入 | 1.381 | 3.029 | 82.654 | 0 | 0 |
總營業費用 | 300.656 | 367.727 | 138.45 | 84.048 | 49.889 |
銷售/一般/行政費用,總計 | 65.978 | 57.386 | 38.588 | 13.742 | 8.855 |
研究與開發 | 246.355 | 292.533 | 96.973 | 70.306 | 41.034 |
營業收入 | -299.275 | -364.698 | -55.796 | -84.048 | -49.889 |
利息收入(費用),非經營淨值 | 8.786 | 0.83 | 3.4 | 8.801 | 1.113 |
其他,淨值 | -0.02 | -0.004 | -0.016 | -0.058 | -0.009 |
稅前淨收入 | -290.509 | -363.872 | -52.412 | -75.305 | -48.785 |
稅後淨收入 | -290.509 | -363.872 | -52.412 | -75.305 | -48.785 |
未計算非常項目前的淨收益 | -290.509 | -363.872 | -52.412 | -75.305 | -48.785 |
淨收入 | -290.509 | -363.872 | -52.412 | -75.305 | -48.785 |
普通股股東可獲收益 (不含非經常性項目) | -290.509 | -363.872 | -230.201 | -75.305 | -48.785 |
普通股股東可獲收益 (含非經常性項目) | -290.509 | -363.872 | -230.201 | -75.305 | -48.785 |
攤薄淨收入 | -290.509 | -363.872 | -230.201 | -75.305 | -48.785 |
攤薄後加權平均股 | 112.234 | 95.1367 | 89.9068 | 86.8757 | 86.8757 |
扣除特別項目的每股攤薄盈利 | -2.58843 | -3.82473 | -2.56044 | -0.86681 | -0.56155 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | |||
每股正常攤薄盈利 | -2.58843 | -3.82473 | -2.56044 | -0.86681 | -0.56155 |
收入 | 1.381 | 3.029 | 82.654 | ||
Depreciation / Amortization | 3.117 | 2.889 | |||
Total Adjustments to Net Income | 0 | 0 | -177.789 | ||
利息費用(收入) - 淨運營 | 0 | 11.855 | |||
Other Operating Expenses, Total | -11.677 | 2.836 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
總收入 | 0.119 | 0.226 | 0.253 | 0.344 | 0.365 |
收入 | 0.119 | 0.226 | 0.253 | 0.344 | 0.365 |
總營業費用 | 106.169 | 101.403 | 73.104 | 86.236 | 78.176 |
銷售/一般/行政費用,總計 | 20.12 | 19.579 | 16.468 | 16.074 | 17.465 |
研究與開發 | 88.201 | 82.827 | 67.277 | 66.9 | 60.511 |
Depreciation / Amortization | |||||
營業收入 | -106.05 | -101.177 | -72.851 | -85.892 | -77.811 |
利息收入(費用),非經營淨值 | 7.559 | 6.941 | 5.372 | 1.713 | 1.005 |
其他,淨值 | -0.014 | -0.003 | -0.024 | 0.007 | 0.018 |
稅前淨收入 | -98.505 | -94.239 | -67.503 | -84.172 | -76.788 |
稅後淨收入 | -98.505 | -94.239 | -67.503 | -84.172 | -76.788 |
未計算非常項目前的淨收益 | -98.505 | -94.239 | -67.503 | -84.172 | -76.788 |
淨收入 | -98.505 | -94.239 | -67.503 | -84.172 | -76.788 |
普通股股東可獲收益 (不含非經常性項目) | -98.505 | -94.239 | -67.503 | -84.172 | -76.788 |
普通股股東可獲收益 (含非經常性項目) | -98.505 | -94.239 | -67.503 | -84.172 | -76.788 |
攤薄淨收入 | -98.505 | -94.239 | -67.503 | -84.172 | -76.788 |
攤薄後加權平均股 | 121.681 | 121.321 | 121.062 | 110.906 | 108.644 |
扣除特別項目的每股攤薄盈利 | -0.80954 | -0.77677 | -0.55759 | -0.75895 | -0.70678 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
每股正常攤薄盈利 | -0.80954 | -0.77677 | -0.55759 | -0.75895 | -0.70678 |
利息費用(收入) - 淨運營 | 0 | 0 | 0 | ||
Other Operating Expenses, Total | -2.152 | -1.003 | -10.641 | 3.262 | 0.2 |
Total Adjustments to Net Income | 0 |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
流動資産總額 | 1019.51 | 976.242 | 770.1 | 360.536 | 424.102 |
現金和短期投資 | 998.917 | 958.073 | 678.061 | 355.816 | 421.505 |
現金等價物 | 151.794 | 280.119 | 447.646 | 41.954 | 421.505 |
短期投資 | 847.123 | 677.954 | 230.415 | 313.862 | 0 |
預付的費用 | 12.11 | 13.229 | 9.385 | 4.72 | 2.597 |
總資産 | 1099.77 | 1008.44 | 799.829 | 393.068 | 428.611 |
物業/廠房/設備,總計 - 淨額 | 75.388 | 27.323 | 28.829 | 31.654 | 3.631 |
物業/廠房/設備,總計 - 總額 | 93.777 | 41.69 | 39.359 | 38.635 | 8.28 |
累計折舊,總計 | -18.389 | -14.367 | -10.53 | -6.981 | -4.649 |
其他長期資産,總計 | 2.578 | 2.578 | 0.9 | 0.878 | 0.878 |
流動負債總額 | 63.709 | 24.321 | 13.632 | 11.986 | 6.865 |
應付賬款 | 10.578 | 8.276 | 6.351 | 6.991 | 4.705 |
預提費用 | 25.426 | 15.212 | 7.084 | 4.662 | 2.042 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
其他流動負債,總計 | 27.705 | 0.833 | 0.197 | 0.333 | 0.118 |
負債總額 | 149.553 | 110.635 | 36.536 | 35.725 | 7.418 |
長期債務總額 | 0 | 0 | 0 | 0 | 0 |
其他負債,總計 | 85.844 | 86.314 | 22.904 | 23.739 | 0.553 |
總權益 | 950.218 | 897.808 | 763.293 | 357.343 | 421.193 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 537.781 | 532.12 |
普通股 | 0.121 | 0.109 | 0.09 | 0.004 | 0.003 |
額外實收資本 | 2019.13 | 1666.89 | 1167.37 | 8.715 | 3.247 |
留存收益(累計赤字) | -1058.61 | -768.1 | -404.228 | -189.482 | -114.177 |
其他權益,總計 | -10.42 | -1.088 | 0.064 | 0.325 | 0 |
總負債和股東權益 | 1099.77 | 1008.44 | 799.829 | 393.068 | 428.611 |
已發行普通股總數 | 121.112 | 108.21 | 89.9068 | 86.8757 | 86.8757 |
應收賬款總額,淨額 | 5.219 | 4.94 | 82.654 | ||
應收賬款 - 貿易,淨額 | 5.219 | 4.94 | 82.654 | ||
無形資産,淨額 | 2.3 | 2.3 | |||
其他流動資産,總計 | 3.259 |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
---|---|---|---|---|---|
流動資産總額 | 831.798 | 884.349 | 958.388 | 1019.51 | 1087.3 |
現金和短期投資 | 810.615 | 871.573 | 937.804 | 998.917 | 1053.79 |
現金等價物 | 151.328 | 145.902 | 161.275 | 151.794 | 354.643 |
短期投資 | 659.287 | 725.671 | 776.529 | 847.123 | 699.149 |
應收賬款總額,淨額 | 0.211 | 0.078 | 5.231 | 5.219 | 5.117 |
應收賬款 - 貿易,淨額 | 0.211 | 0.078 | 5.231 | 5.219 | 5.117 |
預付的費用 | 17.294 | 9.306 | 11.268 | 12.11 | 16.808 |
總資産 | 906.959 | 962.016 | 1037.56 | 1099.77 | 1168.72 |
物業/廠房/設備,總計 - 淨額 | 70.154 | 72.66 | 74.294 | 75.388 | 76.543 |
其他長期資産,總計 | 2.707 | 2.707 | 2.578 | 2.578 | 2.578 |
流動負債總額 | 50.748 | 71.576 | 70.467 | 63.709 | 71.427 |
應付賬款 | 13.353 | 14.778 | 11.834 | 10.578 | 9.485 |
預提費用 | 36.271 | 31.52 | 32.486 | 26.979 | 35.041 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
負債總額 | 128.586 | 151.897 | 154.148 | 149.553 | 168.949 |
長期債務總額 | 0 | 0 | 0 | 0 | 0 |
其他負債,總計 | 77.838 | 80.321 | 83.681 | 85.844 | 97.522 |
總權益 | 778.373 | 810.119 | 883.412 | 950.218 | 999.769 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | |
普通股 | 0.123 | 0.122 | 0.121 | 0.121 | 0.121 |
額外實收資本 | 2098.72 | 2067.43 | 2041.94 | 2019.13 | 2004.14 |
留存收益(累計赤字) | -1317.09 | -1251.35 | -1152.85 | -1058.61 | -991.106 |
其他權益,總計 | -3.386 | -6.081 | -5.802 | -10.42 | -13.389 |
總負債和股東權益 | 906.959 | 962.016 | 1037.56 | 1099.77 | 1168.72 |
已發行普通股總數 | 123.161 | 121.945 | 121.477 | 121.112 | 120.811 |
無形資産,淨額 | 2.3 | 2.3 | 2.3 | 2.3 | 2.3 |
其他流動負債,總計 | 1.124 | 25.278 | 26.147 | 26.152 | 26.901 |
物業/廠房/設備,總計 - 總額 | |||||
累計折舊,總計 | |||||
其他流動資産,總計 | 3.678 | 3.392 | 4.085 | 3.259 | 11.58 |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
净收入/起跑线 | -290.509 | -363.872 | -52.412 | -75.305 | -48.785 |
经营活动产生的现金 | -229.49 | -74.406 | -102.489 | -66.133 | -44.135 |
经营活动产生的现金 | 4.13 | 3.925 | 3.549 | 2.845 | 2.154 |
非现金物品 | 45.643 | 188.197 | 31.544 | 2.017 | 2.896 |
营运资金的变化 | 11.246 | 97.344 | -85.17 | 4.31 | -0.4 |
投资活动产生的现金 | -188.745 | -479.511 | 81.672 | -319.024 | -1.68 |
资本支出 | -9.062 | -3.471 | -1.931 | -8.002 | -1.687 |
其他投资现金流量项目,总计 | -179.683 | -476.04 | 83.603 | -311.022 | 0.007 |
融资活动产生的现金 | 289.91 | 388.09 | 426.509 | 5.606 | 394.972 |
融资现金流项目 | -2.507 | 0 | 0.717 | ||
股票的发行(报废),净额 | 289.91 | 388.09 | 429.016 | 5.606 | 394.255 |
现金净变化 | -128.325 | -165.827 | 405.692 | -379.551 | 349.157 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -94.239 | -290.509 | -223.006 | -138.834 | -62.046 |
Cash From Operating Activities | -67.13 | -229.49 | -172.411 | -106.266 | -49.173 |
Cash From Operating Activities | 1.197 | 4.13 | 2.964 | 1.931 | 0.975 |
Non-Cash Items | 18.498 | 45.643 | 42.755 | 25.434 | 9.541 |
Changes in Working Capital | 7.414 | 11.246 | 4.876 | 5.203 | 2.357 |
Cash From Investing Activities | 75.314 | -188.745 | -41.809 | -68.996 | -112.384 |
Capital Expenditures | -1.915 | -9.062 | -6.746 | -4.651 | -2.794 |
Other Investing Cash Flow Items, Total | 77.229 | -179.683 | -35.063 | -64.345 | -109.59 |
Cash From Financing Activities | 1.297 | 289.91 | 288.744 | 2.879 | 0.883 |
Issuance (Retirement) of Stock, Net | 1.297 | 289.91 | 288.744 | 2.879 | 0.883 |
Net Change in Cash | 9.481 | -128.325 | 74.524 | -172.383 | -160.674 |
Financing Cash Flow Items |
差價合約交易計算器
如果您在特定日期(選取一個日期)開立差價合約交易並在不同日期(選取一個日期)關閉交易,計算您的假設盈虧。
交易佣金
0
- 1:1
杠杆
1:1
- 20
- 100
- 500
- 1000
- 10000
投資
交易規模(槓桿 x 投資):
打開
關閉
做空 做多
Relay Therapeutics, Inc. Company profile
关于 Relay Therapeutics Inc.
Relay Therapeutics Inc.是一家处于临床阶段的精准药物公司。 该公司专注于改变药物发现过程,最初的重点是加强肿瘤靶向治疗的小分子疗法发现。 该公司正在推进解决精准肿瘤学目标的药物管道,包括其主要候选产品RLY-4008、RLY-2608和RLY-1971。 其RLY-1971与含Src同源区二(SH2)的蛋白酪氨酸磷酸酶二(SHP2)结合并稳定其非活性构象。 其RLY-4008是成纤维细胞生长因子受体2(FGFR2)的抑制剂,富含致癌FGFR2的晚期实体肿瘤患者。 该公司利用其Dynamo平台专注于精准肿瘤学。 它还在推进几个早期项目,专注于其他精准肿瘤学和遗传性疾病目标。
Industry: | Biotechnology & Medical Research (NEC) |
399 Binney Street
2nd Floor
CAMBRIDGE
MASSACHUSETTS 02139
US
收入報表
- Annual
- Quarterly
人們也觀看
还在找一位您可以信任的经纪商吗?
加入成为全球610,000万多名交易者的一份子,选择利用Capital.com进行交易吧。